103 Recruiting HIV Infections Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for HIV Infections
Related Conditions
Top Recruiting HIV Infections Studies
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
📍 University of Illinois Chicago — Chicago, Illinois
View Study & Checklist ➔The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
📍 CUNY Graduate School of Public Health & Health Policy — New York, New York
View Study & Checklist ➔Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔Clinical Decision Support for PrEP
📍 Saban Community Clinic — Los Angeles, California
View Study & Checklist ➔Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
📍 Johns Hopkins Hospital — Baltimore, Maryland
View Study & Checklist ➔A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV
📍 GSK Investigational Site — Las Vegas, Nevada
View Study & Checklist ➔Accelerated ART Initiation for PWHIV Who Are Out of Care
📍 University of Missouri-Columbia — Columbia, Missouri
View Study & Checklist ➔A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV
📍 GSK Investigational Site — Long Beach, California
View Study & Checklist ➔Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix
📍 Medicine Invention Design Incorporation - IORG0007849 - NPI 1023387701 — Rockville, Maryland
View Study & Checklist ➔Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
📍 Alabama CRS — Birmingham, Alabama
View Study & Checklist ➔Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders
📍 Vivent Health Clinic — Denver, Colorado
View Study & Checklist ➔Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study
📍 VA Medical Center-Los Angeles — Los Angeles, California
View Study & Checklist ➔Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
📍 GSK Investigational Site — Los Angeles, California
View Study & Checklist ➔APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies
📍 Memorial University of Newfoundland — St. John's, Newfoundland and Labrador
View Study & Checklist ➔Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔Trauma-informed Care for Youth With HIV in Memphis
📍 St. Jude Childrens Research Hospital — Memphis, Tennessee
View Study & Checklist ➔A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
📍 GSK Investigational Site — Mobile, Alabama
View Study & Checklist ➔Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
📍 Alabama CRS [31788] — Birmingham, Alabama
View Study & Checklist ➔A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV
📍 Beth Israel Deaconess Medical Center (Site ID: 32077) — Boston, Massachusetts
View Study & Checklist ➔Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs
📍 Prevention Point Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Consent for Use of Stored Patient Specimens for Future Testing
📍 Univ of Southern California / LA County USC Med Ctr — Los Angeles, California
View Study & Checklist ➔The Cheeky Study: A Novel Delivery System for CAB-RPV LA
📍 Bridge HIV, San Francisco Department of Public Health — San Francisco, California
View Study & Checklist ➔A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
📍 GSK Investigational Site — Bakersfield, California
View Study & Checklist ➔Infectious Disease (ID) Testing OUtreach in Carceral Hubs
📍 South Bay House of Corrections — Boston, Massachusetts
View Study & Checklist ➔A Simple Intervention to Increase Persistence on PrEP in MSM to Improve Decision Making
📍 Boston Univeristy School ofPublic Health, Global Health — Boston, Massachusetts
View Study & Checklist ➔WiseApp for Spanish Speakers Living With HIV
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services Programs
📍 University of California, San Diego — San Diego, California
View Study & Checklist ➔A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
📍 GSK Investigational Site — Birmingham, Alabama
View Study & Checklist ➔An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department
📍 The University of Texas Health Science Center at Houston — Houston, Texas
View Study & Checklist ➔The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study
📍 Research Institute of the McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔PrEPwise Pilot Among Black Women in Eastern Virginia
📍 LGBT Life Center (5360 Robin Hood Road, Norfolk, VA 23513 — Norfolk, Virginia
View Study & Checklist ➔NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings
📍 Duke University Medical System — Durham, North Carolina
View Study & Checklist ➔Precision Microbiota Interventions for Senoreduction Trial
📍 LSU Health — New Orleans, Louisiana
View Study & Checklist ➔Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔Improving HIV Prevention and Substance Use Post-Sexual Assault Services
📍 The University of Texas Health Science Center at Houston — Houston, Texas
View Study & Checklist ➔